IMMU-02. Is Dual Agent Immunotherapy Shifting the Epidemiology of Melanoma Brain Metastases? A Real-World Analysis and Single-Institution Validation
Publication Date
11-15-2023
Presented At:
Annual Meeting. Society for Neuro-Oncology (SNO)
Content Type
Presentation
Publisher's Site:
Citation
Bhanja, D., Wilding, H., Moeckel, C., Hong, J., Baroz, A., Stahl, C., Ozair, A., Dao, J., Sivik, J., Drabick, J., Pameijer, C., Ahluwalia, M., & Mansouri, A. (2023). IMMU-02. Is Dual Agent Immunotherapy Shifting the Epidemiology of Melanoma Brain Metastases? A Real-World Analysis and Single-Institution Validation. Neuro-Oncology, 25(Supplement_5), v141-v141. https://doi.org/10.1093/neuonc/noad179.0534